Home › NCT00722527

Molecular Biology of Polycythemia and Thrombocytosis

Who can join

All ages · All sexes

Inclusion Criteria:

1. Subjects with an elevated hemoglobin concentration (\>18 in males and \>16 in females)
2. Subjects with an elevated platelet count (\>450,000)

Exclusion Criteria:

1. Subjects who have a known acquired cause of polycythemia and thrombocytosis
2. Subjects with heart disease, left to right heart shunt or severe pulmonary disease

About the study

Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.

Sponsor: University of Utah · Participants: 200 · Started: 2006-07

Contact the study team

• Josef T Prchal, MD · Phone: 801-581-4220
• Soo Jin Kim, MS · Phone: 801-213-4379

Official record on ClinicalTrials.gov — NCT00722527

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.